Latest filing published 11 Sept 2026 for 10x Genomics, Inc., €66k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Adam Taich across 2 companies, led by 10x Genomics, Inc. and SomaLogic, Inc. In total, 13 filings cover trades dated from 2 March 2023 to 9 September 2026.
The open-market record consists of 10 sales worth €4.5M, with no purchase. Outside the open market, there are 2 share grants. 2026 to date brings no purchases and 6 sales.
The newest entry dates from 11 September 2026: an open-market sale of €66k, in 10x Genomics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations